<SEC-DOCUMENT>0001628280-22-016413.txt : 20220607
<SEC-HEADER>0001628280-22-016413.hdr.sgml : 20220607
<ACCEPTANCE-DATETIME>20220607113208
ACCESSION NUMBER:		0001628280-22-016413
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20220607
FILED AS OF DATE:		20220607
DATE AS OF CHANGE:		20220607

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CYBIN INC.
		CENTRAL INDEX KEY:			0001833141
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40673
		FILM NUMBER:		221000333

	BUSINESS ADDRESS:	
		STREET 1:		100 KING STREET WEST
		STREET 2:		SUITE 5600
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1C9
		BUSINESS PHONE:		(908) 764-8385

	MAIL ADDRESS:	
		STREET 1:		100 KING STREET WEST
		STREET 2:		SUITE 5600
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1C9
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>cybininc-form6xk06x07x2022.htm
<DESCRIPTION>6-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8a9b7e90ef7b4359a8680c6367d3c6e5_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Washington, D.C. 20549</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Form 6-K</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16<br>UNDER THE SECURITIES EXCHANGE ACT OF 1934</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the month of June, 2022.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commission File Number&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">001-40673</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Cybin Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Exact Name of Registrant as Specified in Charter)<br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Address of principal executive offices) </font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Form 20-F  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:115%">&#9633;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  Form 40-F &#8864;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)&#58; ____</font></div><div><font><br></font></div><div style="margin-bottom:11.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders. </font></div><div style="margin-bottom:11.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)&#58; ____ </font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58; Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant&#8217;s &#8220;home country&#8221;), or under the rules of the home country exchange on which the registrant&#8217;s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant&#8217;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR. </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">INCORPORATION BY REFERENCE</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exhibit 99.1 of this Form 6-K of Cybin Inc. (the &#34;Company&#34;) is hereby incorporated by reference into the Registration Statement on Form F-10 (File No. 333-259994) of the Company, as amended or supplemented.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SIGNATURE</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.<br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:5.048%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.696%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CYBIN INC.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Registrant)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">June 7, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#47;s&#47; Doug Drysdale&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Doug Drysdale</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">EXHIBIT INDEX</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">99.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="cybin-newsreleaseannouncin.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">News Release dated June 7, 2022</a></font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>cybin-newsreleaseannouncin.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="idf44ad9bd45f4c789b0a0fbb84699bbe_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:1pt;text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:234px;margin-bottom:5pt;vertical-align:text-bottom;width:325px"></div><div style="margin-top:1pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:139%">Cybin Acquires DMT Clinical Study from Entheon Biomedical</font></div><div style="margin-top:1pt;text-align:center"><font><br></font></div><div style="margin-top:1pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:153%">-- Acquisition of largest Phase 1 DMT study conducted to date is expected to accelerate CYB004 program timeline by nine months --</font></div><div style="margin-top:1pt;text-align:center"><font><br></font></div><div style="margin-top:1pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:153%">-- Phase 1 study evaluating pharmacokinetics&#47;pharmacodynamics of DMT currently underway and will inform clinical path forward --</font></div><div style="margin-top:1pt;text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">TORONTO, CANADA </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8211; June 7, 2022 &#8211; </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Cybin Inc.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> (</font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">NEO&#58;CYBN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">) (</font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">NYSE American&#58;CYBN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">) (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Cybin</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> or the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">), a biopharmaceutical company focused on progressing &#8220;Psychedelics to Therapeutics</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:133%;position:relative;top:-3.15pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;, today announced that, through its wholly-owned subsidiary Cybin IRL Limited, it has entered into an agreement to acquire a Phase 1 N,N-dimethyltryptamine (&#8220;DMT&#8221;) study (the &#8220;Acquisition&#8221;) from Entheon Biomedical Corp. (CSE&#58; ENBI) (OTCQB&#58; ENTBF) (FSE&#58; 1XU1) (&#8220;Entheon&#8221;) to accelerate the clinical development path for CYB004, Cybin&#8217;s proprietary deuterated DMT molecule for the potential treatment of anxiety disorders.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The Phase 1 EBRX-101 study, now named CYB004-E, is being conducted in the Netherlands at the Centre for Human Drug Research, a leading independent foundation specializing in innovative early-stage clinical drug research, in 50 healthy volunteers who smoke tobacco &#8211; making it the largest Phase 1 DMT clinical study conducted to date. Pending the close of the Acquisition, the CYB004-E study is expected to yield essential safety and dosing optimization data and will replace Cybin&#8217;s planned pilot study for CYB004 that was expected to commence in the third quarter of 2022.  Entheon will continue to support the CYB004-E study and act as external consultants to Cybin.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#34;The most precious commodity in drug development is time and acquiring this robust Phase 1 study already underway potentially accelerates the CYB004 development program by approximately nine months.  The PK findings from the CYB004-E study should also help to inform the clinical path forward for this innovative and proprietary molecule,&#8221; said Doug Drysdale, Chief Executive Officer of Cybin.  &#8220;This transaction also provides Cybin with access to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">a world-class research foundation and the privilege to work with the Entheon team, who offer a wealth of knowledge and expertise in this psychedelic class.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The purchase price of the Acquisition is $1,000,000 (CAD), a portion of which will be a deposit with the balance payable on closing of the Acquisition. Up to an additional $480,000 (CAD) is payable for consulting services to be provided by Entheon for up to twelve months following the closing of the Acquisition. Pursuant to the Acquisition the Company will also enter into a data license agreement with Entheon that will permit Entheon to access certain data to support the Entheon IQ program. The Company expects the Acquisition to close within 30 days, subject to the completion of certain conditions and obtaining all necessary approvals.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8220;With our recent IND filing for CYB003, we are quickly becoming a multi-program clinical-stage company with four sponsored human trials underway in 2022.  This is especially meaningful to our work to bring our innovative psychedelic-based therapies to people in need as quickly as possible.  This is a truly exciting time for Cybin,&#8221; concluded Drysdale.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">About the CYB004-E Study</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">The CYB004-E study is an adaptive, randomized, double-blind, placebo-controlled, single ascending dose study to evaluate the safety, pharmacokinetics (&#8220;PK&#8221;) and pharmacodynamics (&#8220;PD&#8221;) of a target-controlled intravenous infusion of DMT in healthy smokers.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Primary Objectives&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Evaluate the safety of increasing doses of a single dose continuous DMT infusion over 90 minutes&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Characterize the PK of a single dose DMT administered continuously over 90 minutes&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Characterize the PD of a single dose DMT administered continuously over 90 minutes&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Establish the minimum DMT dose required to produce a psychedelic effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Pending results from the CYB004-E study, Cybin plans to evaluate CYB004 delivered via intravenous (&#8220;IV&#8221;) and via inhalation to determine the clinical path forward.  Based on preclinical results reported by Cybin in April 2022, inhaled CYB004 demonstrated&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Approximately 2000% improved bioavailability compared with orally administered DMT, which is known to have limited to no oral bioavailability&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Approximately 41% improved bioavailability compared with inhaled DMT&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Approximately 300% longer duration of effect when compared with IV DMT, indicating potential to extend therapeutic window&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.15pt">Rapid onset of effect and similar low variability equivalent to IV DMT.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">CYB004 is a new chemical entity for which a patent was issued by the U.S. Patent and Trademark Office in February 2022. The allowed claims include a range of deuterated forms of DMT and 5-MeO-DMT. The composition of matter patent is expected to expire in 2041 before consideration of any patent term extensions.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:139%">About Cybin</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. The Company is focused on progressing Psychedelics to Therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:139%">Cautionary Notes and Forward-Looking Statements</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Certain statements in this press release constitute forward-looking information. All statements other than statements of historical fact contained in this press release, including, without limitation, statements regarding Cybin&#8217;s future, strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words &#8220;believe&#8221;, &#8220;expect&#8221;, &#8220;aim&#8221;, &#8220;intend&#8221;, &#8220;plan&#8221;, &#8220;continue&#8221;, &#8220;will&#8221;, &#8220;may&#8221;, &#8220;would&#8221;, &#8220;anticipate&#8221;, &#8220;estimate&#8221;, &#8220;forecast&#8221;, &#8220;predict&#8221;, &#8220;project&#8221;, &#8220;seek&#8221;, &#8220;should&#8221; or similar expressions or the negative thereof, are forward-looking statements. Forward-looking statements in this news release include statements regarding the Company&#8217;s proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens to potentially treat psychiatric disorders, the anticipated timeline for closing the Acquisition, the Company&#8217;s expectation that the Acquisition will accelerate the CYB004 timeline, and the Company&#8217;s expectations and objectives regarding the results of the study.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include&#58; implications of the COVID-19 pandemic on the Company&#8217;s operations&#59; fluctuations in general macroeconomic conditions&#59; fluctuations in securities markets&#59; expectations regarding the size of the psychedelics market&#59; the ability of the Company to successfully achieve its business objectives&#59; plans for growth&#59; political, social and environmental uncertainties&#59; employee relations&#59; the presence of laws and regulations that may impose restrictions in the markets where the Company operates&#59; and the risk factors set out in the Company's management's discussion and analysis for the period ended December 31, 2021 and the Company's listing statement dated November 9, 2020, which are available under the Company's profile on www.sedar.com and with the U.S. Securities and Exchange Commission on EDGAR at www.sec.gov. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Cybin makes no medical, treatment or health benefit claims about Cybin&#8217;s proposed products. The U.S. Food and Drug Administration, Health Canada or other similar regulatory authorities have not evaluated claims regarding psilocybin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds. The efficacy of such products has not been confirmed by approved research. There is no assurance that the use of psilocybin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds can diagnose, treat, cure or prevent any disease or condition. Rigorous scientific research and clinical trials are needed. Cybin has not conducted clinical trials for the use of its proposed products. Any references to quality, consistency, efficacy and safety of potential products do not imply that Cybin verified such in clinical trials or that Cybin will complete such trials. If Cybin cannot obtain the approvals or research necessary to commercialize its business, it may have a material adverse effect on Cybin&#8217;s performance and operations.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Neither the Neo Exchange Inc. nor the NYSE American LLC stock exchange have approved or disapproved the contents of this news release and are not responsible for the adequacy and accuracy of the contents herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:139%">Investor &#38; Media Contacts&#58;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Leah Gibson</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Vice President, Investor Relations &#38; Strategic Communications</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Cybin Inc.</font></div><div style="text-align:justify"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">irteam&#64;cybin.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> &#8211; or &#8211; </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">media&#64;cybin.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
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MT8Q8GV%%Z%A3M6&OB;ZB$@2$ILZE9;)FVCV8UD32V*( =O$$*Q[;D"?=R(=
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MMG!9I+\*:;LXK4?T3UJ-';F6T6,:]UGF.0:?,+%N-?$X[0H7:H)P= Z\\GK
MT6 Z(G @A#Q<5< B<,'AQ"&*4#75ZQL4+ OU08**T*Y/FDT;L7':$?!Y.D3:
M/;,"U38!D6&T.8B0CR!RIK*3^#YO=]/.+_[0ITOZGE[\B"TN_JECF*7$[$U"
MB*-S\6/ (32]QCIL.4UIR2?%.Z[.12D]G@GR\,ZN_U)6;ZLKG(XI.S[YTLR%
M#*%*BSR6A!B:1)\PK0;S\-BD"(DAK*?BM- I=L98LM6%6A/R96&'^% LCDP;
M&Z&=2?VDG2^+-1A"'D9 8J2BJTW,X;TU51MKS>Y(:8AD$&)#=J$JM(O XS8!
MZ@9!!E.09.M6LAI;7>%T3/<5VM,8(=1TV@VT=6N3FI WDJGC\-[:A;1>'<PQ
M=O"6J#*:*?O8'.%"9HC0ZM_%Q=_\22LZD"A[']H,#<4F_/W'J( $,T8"^F8F
M=O2 N,+$6 CIE&^9&(!3J+NX],[KEH1*-#9! =VK%#'41"U+B76FXBG>HHDA
ML5$H.-Y,K+HLW@Y=-8?*F!>;22AE)C!!6=*_G1:'D,M)9#%C!#51>3.QA?@A
MF1&R/ Y"O$]#0@#I8<-WB$R@@4- 59ZV=!48/?K8 D*-96 #Z%W.,C_*7"J$
M*<8Y,8K=P4Q"Y%H)>L%B1Y>X!#CH;H"7:/N-0M!,K&99L@>\7$D+%[^\%!"U
M/#-J*((";VQ)G,9319R(X!E)&9GLCI:-6"B,IH) G")58<\Z+0CSIY]T3,4K
M#AMB5LBWCN+S9;VP+()%H6EA$G(Z. 'H1JFQ!NRKKB?D)E"'+<)$NFL2YI=3
M"L2C"I%L=4TDJGY,[I#EJ")<<LS&ZNW/,EAU$C:J$#<G7UW>$RM5438*6347
MZ%F69I" A=XSL* 9+*K%:A<2$4H0:<MA%[I$3>KJ;@ ,(>LOCO&E:A*BZJTO
M_AW^[Z\#&YK!-,/R6.B7NQID (O3+.K!4/K/DA#2)&D*HA/F6YXVJQ UJM '
MV !DQ-9%".T9E7NH&Y?%*[!/AQ"/SLP+$]HV)^BR*%V$)"MDA"0!'UD747!\
MFN'C.)&GU9V*A6:F#X.4!#./SL4?_-E9GE[\!*IT,_"ZPZ^:*Q *623FE(#K
MJ<H+BY!DE=:M4*(0U@=\6)9&:-7V"0CQN9-GI]UHSXY;(0$'*+V),(/W9"Z]
M5T FC0.E.39G:)]%(=WG=N['5"!C"O3(O7JJ0>R:*5&H)R>/$H@,BJ0^@3>A
MVK6E$-373/$TLZT@-)&&0K1")<A<S)W 4A=3H&M H0IAV/+BAX2F5T,UV"BD
M^]S._1PAQ+[BI5MF(Q3-%BD.0D/!=QI,:*@&T!4I-RG!*;,:"H$DVS!MA0:;
MC(9"C'!X/]:0WQ;[),TSBSHX[4J>8QYRH48*NX+0 DH++ Q/'T*\%+44 5HT
MT^I.FD:ATK(0!JHUNQ%2"D434+I-&!"A>9M,95\ TR9(>TP(.6%9YG,H?-JZ
MGEDH)4A9I1*\26D1*^99B'EPX[1*F=!2M]H""ZUV\>+7_-(H8%$(["2T"UAZ
MD<*)430A2'<) ZO0KLG*5/9WQHW56^1ELU?@5_!BL!D.].)K&1 P!N+&JA#-
ML()!-)D)\22:&L&,2I@9@6J:P\U@K3F'CF8FQ+-" C0CUA<C+XL*0=_F/,,1
ML)![L!\!:(]YPPW+,G9%1I"FC;'QH:Q8EBUL%LI-XN7D>=XI></&=0OP88H0
M=_!>(:ZT>R*=A&!:;F:I46WI+*=<#L9R$%(I2XB=I%3()!07GP@S(X<;Z$ ?
M[)L"28(0L2IDRZ()4; LBP=,R)FQC?52)#$5$@_V%% AZ>XHUV14!J0F 111
M>;$T6]DL-/[RRM*LH?=0QH%Y'>#X0QXVSPV*D \HIA+>W!&FS:T[!E"F#4(K
M_0!.4M.U@GG>Q BXML(>'&N ;4+7IF\AP+'8,!(9K 9P=&$H<Z#:6P^^!HQ)
M2ZPD^YG4?:GVD-LA,HBP"\EA!#PI.;E<DTQVK&-Z.>FV:5"$0@T2WMPAU>W:
M)K_D2,.Q#9%=7_R^Z[&;90FIV+4(%0(<BPT#2$L.51'+EU.<REL/'@/ZWU\/
M>T4?'FSD0WPT(C=LQK[4#1AI)\[ITDD)2V$O<^)[T%.'X>E,1PUE0I; 9XS+
MXK0Z8[>J7Y0US'P\PX9 LDH1@GVZV+J6\039-@L!JJ"(U-:XD20)(2U\=SG5
MEL"826FHUB6!X_EY;YL55K86973=D4!*6X:-:%48>10O?H G6&T1\JO'-I8<
M]Y.+OSO+HZN6BI\TE E9"B-W??%#!'Q@V%1E% ),!9,X)$C4VW1"*_Z3UKN%
M,&#T,933""TY$ +B^#'M'M.RC4*3PPGHFF1[UI3LU'E70J'Q+C$MVRB4CZQ#
MUV0C5O.Z:8M903=MGW"T,)VV$6HH1C<M[:85/=JC1_1"J[9RNR83=$+!WK50
MUV27F)9M%)I,V]:-UUC)GF8J,\B1RWNAZ0N]IW,GS21S?$73KR2U+R'17IY#
M-(5KB)'DB^FV3!83H5SC,('7JDV'#"3V,D,#'#53$J3&O]A3G,W41!UUM=)8
MB,Z$D.!=M*NAE6*&KAS0L->Z2."##57C@Z\.HY/0I$D:A':8R 0HT5;W "[$
M5D;S#GIH+HKYQ0_-P[I19:OM2+0*U1!-$36DMRV; @O-3DO"E OYQ<\:'-=$
MK;+%%Q*4@M#RLC -X0H4$C<T#)9$2=/KG%6"=]&N1DH,73FB<>M+.4**Z7\@
M@-T8@^P"D2CA NS19MN D<#39F3?@=&?9^>*IT*1#&R.$=,)E6EK9:1PPB;7
M^!S;1LB!S3$QV+D#^YEEHK""R5%X;ZDN2?EP-F$%/2"[%#K1'DX8K!03V046
MIRW9T+QK-B"DQR0]"Y'?=F!TUV3(+RUZ(9NVQ6H+H>RI4**0K7*2D -YVI(0
M8"K)1I2+GU%8(@HKJ,WUO0+LBY>E<".P&=I?Y\%^<<FME@78U@U'L9C(S,"U
M;3L1UU[V]6(H>CI DRP((V'7#!*2"CL<XF5X.%ZR5$A][M!,2W9:%J&Y,P"+
M@(LF=]HHA.!D3M<F4.1)&9A"!S<L4>"=6 K)+%M+J\),>P]?138D)16!D/ V
MG/E8P^U&H;2T,'<"FZ$".F[8>N\1=[-N.!?Z,HE*3%A'VTFA]H)U2Q>_6I@D
M!"X#,5!IM AQG#Z$U/0\OPI9+Q:B-&L.[37/-R)D&=5R5R5D.SZ@(2Z+A",&
M(4FB*)D:Q#T"4VA:[@0[L<I[!8@5FC8*7&Y#.6D[VG)"4T^0)NX@LH_P$O[8
MA)"2II5!D7$XTVBAXQ/ME"-B,@A%N:2RN&C6%*Y2A8CP!S-+K002;1XH$DIG
M6="2&39'0[J &OWEQ%8FVVER0T<^NH @%/SL.#6[^,&9+CX,*69. C^'H(0_
M2*AD.4;(A7!J.P:.F*E,8RU1 1H/>YT6>,#*/YKH #0K&8,P<J.0;B6:#UZ;
ME;,L:,D ^.&5:HQ/+]2#7*E9>T)A="T)SKS3@QM"^,$)H3TJ.7([68%)G8NR
M; QE*UZG8HX6K$!A%</.G-$):;;OV"9'&4N =59'A$)#0R-$V<Q8KT"K*]NT
M*#%D#+BUHRU+I"7DKG<.[1U)P5EJ3S5T$IQV652!!A9'=G*6]9-W=B[@I&"=
M=@$%V5G2Y.*G@##&AUYN)*>:?):=Q\IV<A:J!7+$[NJ."Y8N_N"&Q<4TSY@)
M<6>*:9<HM.E1YN'O\N)W6FJU;62'Y;,*C7]YE=HK6M4$K&\3 B89$SI@:5#"
M4DRQS;2>,\EP>IZU42B?^0Y)J,5FH4PTP)QM\EMLG':U[;1MI$-Y8#!:,L&%
M)MF);K,V'D[ )&-"!RP-2H [Y31QFVD]9Y+A]"1A9SLAQR3CJ BUY )VFV^
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MX;.0-W4F"Y6+'\='"IN$SDF4(>T@KPCUA9%N1<E+$\!IGR]+$L3F(64J%(A
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M%%3SKED6\=3B3TJU%GJ6-:C]7,,5)*#]]:*T2"SF/#O+*D01^53;-Y0(.;8
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MMZYB ::@(P0A'L$T36B0T#8K?/3C7[[JZK__V2?^[W,>\,SCS]Y_[-[UG?3
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MJRC*6"O^-S$$DC#" XD1C(4?2HWB%<8=:XC-B,X",&E.-M[HLPR94].0"H*
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MG[1BY:9_(Q-IBIJ Q 4.3Y*$&HB7J$H1=RF&Q,#8DF6?NUM"_ZD55*,J_A
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MYK*((E(<(&1'G0F%'"BK5+J >KH),:*U(,$HDDL@'INER,:Y>T/7^.$E#S<
M= B-C'S0=6=W_9OV2B#("D]"+[ZZIMN!P]OUJL69[=[__%(^/"AD=:X]M^M5
MYQI>%7S"'W=#@+@ASUW_>C8HD*S8ZN3'R-UYB0!5LE$IQPSZI[0[PUP5NO?!
MI;*> $-QY0=PU<^-):DC$T7^&$;E_A.&_>M??&6-26^%WOG LWQ+P5E0&=FW
MS]"^AX_^Y#/9LEL2VE.Y_-+RK_U+,'GN45#Y72=^\UT+.5'(V6LKOCGJ]$E[
M=ZG>3W\LYW_J*D@+POD,ZL\B"($ZT Y66GCR&?6UFW*?H(!HO\:5'U.*J_:T
M\@NW)#2<2H@2%H=U5*Q(6<EG33'DL&Q@JHX@(F>Y=/HL@X$"C@*RAA$37F_9
ME;XPB6J/J1F:HGZNVKEJ9/9!*E(:<E3 $<C%7$VZ!8J*8[(<B:(L<,SOVW:=
M??G,5KQ5+7G)NL6U(M<YNC["2"A;\3E5'W^Z]J 3Q[NAC0@/8N4(B.M)G0UG
M7#S=W>;?>N\B-P3C=RFV@."SI>O__F2LR7K4.>D:_,H.A9,0?@JA'O^)&=+-
MA8<5Q-#@Y PX>NS<)\-WS,7EER$_L6B5?X8+E_:@13(.=<SE_<&&E^*4"JZ[
M_<E6LO*A)&<[W?BQ]V&C/OSXYSA98JAK#OZ#*^5/E5ER2Q5LJCAUYGM:B(-G
MGE_=]XC1[A+K>TQ.;OP&0N(BT_[W.&EIW:/VH./'?P:KO6A%I"UQ8P(%'(%<
MP%!NAJ(LL0+L*;^ LI;VO"JI7\(41@]X0:>,A*QD,J5(FDPT3H-1^DB@% 5D
MU\[=%UPU"^;0#),[$;I/P: _TG,K50^$XA\V=1DX[/6WO@6I)#Q5A %EIZ*'
MD92]H"H1@ (-<!]D08)GDG*8#L*BP N,K061S/OJZU^[+FP_/W.3W4+."6YI
MT:7Z+W][8M<N6$V.# (9D1TARL.Z]5O/O&0&SS0(=X(H5CG9'UO =SXX'OQU
MT_83SYO6!F;40B]/]Y7X<_W+E3?-IX53)6/6+6O7;SWN[,E> BC2PU+I", >
M>D8)YOGG@Z*(QG$#&EIT&7+2^5,_6/D3RZ9,RD^18QP-<FZZ^>ZG6X(?H!O%
M9YK*&S ;_^S+9FR+YC8Q[-RU^\*K'_?5&&TFRX.0??<?VN/0$?)R5;F&ZB2&
MG,^NO'D^=M"<V;CRH[1>AX[\^%/LIBDSLQ=\U.V@X?PRD%*!,XTE2A16)^YG
MN79QT/_V[CSDJK\^@5_Q@9^42U4>RK:5Z5-*U^"E%51^5$0%% DMPD@$::Y0
M^461G$01@Z"!#3]IM60.1+HT1)Q_#&)S$CP"UQYZPWP :)_J!V5LZH&ZD>G$
M;<]=EMT]\KE7S"JJ\3E?)>:HHN5# !_,YBH&CDL5YI (CT!'_?T?BWV;EUPG
M_G&WC6Y M/!9/\O*6)L#B=S56/K;/8M\KZHEB\]#\_,_-R0\Y<)'>8T5#P_4
MO<CCS3"Z1"&N?[GHZMD[=^*:H>S38)7'WO_HQYZ'C*2GNJ*7A4C;1H'1U_>!
MTX]5:RZ^;NYW/P3#LO['0 7GO_OA]ST.'@Z3!,)P6+SM;XU[UPTX9LSG\)U"
M"INW;#_I_&EM^6.PU%HW'':W%"MX&T0$[E,#_/3SEL-.>9@_*C.=.S[V08KK
M><^Z=,;OV\)SY"DSWW75@ Q0CTUQE"J73.JL1:QM4REE7QC(T[*0E>I5I3B!
M"O[7I$R4 HK-E;)'*B:.ZT-SF!4/OKQ"0I)6K*<K1;!*<PJ7#@ : A@GEQ9%
M)(Q)D ,5H0.//,9/#[DA4;NB(U]LL0$CXG'ZWM']W"5ZE%[L,E7$)A+J,:K2
MJ;400?]"$("(()8/G%JS:GI.$9R\O! 1G4'SU]]N''3\>/HV"5V$KL V !0W
M[COY@FF_P;HSJ;64@UA\>=1$OZM8!_D:7?L?WWB@HH'^TC7HN/&R2!W"Q&EO
MAP7Z8#( %I#_+KY'K;L+X6&.A\0QY06+/FG?NZXC3NWR=Z#PMEI&3^KM)01]
M9X=1H7H,:-B[RQ WB%ZW/KS 046F,"5.HBG"1.YJW.V&_#AH1>$TB.:.ID,_
M_XG!DA<_5Y*P)GCTE[6_'7+21%JC*UCK1[XN7_Y3U_WKW7U56/%:F:6;PRNO
M?]UYX##7OTL?"K[ERL]=K<OXO8.72*H%BU:Y@I"GY%0QU&V?N$Z\RO@PN)#@
MK0 4(OY(CF]EN/0$3FZ%.HE9%^7&?O*[\K\0=02XC?X-BYREE1DR!B2$=5N'
M T $5WY%%"RHXH!/8F,4OX_AEU?:-*:DU#@'*A;9^6#!TC,,*4T3,+F[!;OK
M:1DTT9%[#?G1!!'X8=61:N>NJ&[@\Y$\NDJMQ4!E:S&?EAH)L04$T5&*6!$*
M32%.9"3'5I2GSGRO=?=:GG8>? +O'*@;:M6M>LRDY-*2Z-:$I<N^<-+V@8[
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M[!;_,\VH<7?ISU?/AEN$<%&7OJ83Y,N-6+-W2(,?6M8*=O!&:U61418ZPM?
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MWWRWZ9"3)[AJR?46RH[J+7:.GN(&I%?]]0DE(< GJ]?V.6(T.LU?8^3N!(2
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M)K*(4?B]1NTFPI46H]"0?-I O/IO3Z@V%KO%]4=M>\0?5CZU^-,#3Y@ >S'
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M259!T8\_;S[LU(?#PL#8/G5GP0U88O'GFL0YE\_$;U=B+Q5"ZHLDF>J%^1!
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MQ<^6M8HZP*8C3RU>19QQ.B$8S?ROXC&.DQ!OS!1;*T(IGB6#V\!_$F%!K(A
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M0)+7<OG5U[\^XK2'6W09TA'[)LD@=JG\X'*?/D.[#!R66>+/*)* 6)N'(CJ
M:MP)W_V#E[;04_31Y^1\NA+X':AZUCXVV^]D)0(BPQ!E18D: I4ZL 3K\F&"
M7-HX70I$S)1RAA1!42E72I14"%7Y(WH&I=1!KP4=3GA(D:&9@-8HC#G3LJ0
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MJEN-&ZO&EHB=H4OE'FI @^N%CS]GRD>?_!0$Q]8EWD\XBEB,Q0E'$7RQ9L/
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M?MIC('V!X!I@4N,0LL-1<<VK-&I)>AZ;UT'@RV)-QBOYLBQF$X0X&H+;B2.
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MTB[+RN++STETPR0EB-*\QTQT\K3F):&#MBL:10@UV4'9L=L@65_\X!@K7$+
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MLC10G<20(X02F)"VSJQ.VY?V:+4CIH5<+>N/JGLSP6*EBX&2GM:C:WQ8Y/2
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MG8'GCV<#=XJQL:S5<4TCU-NHV &=@AXBR<^^^-[Q#M[^R@#S0]ZA*^ZGD'K
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M*)CROFG,X>J04%S\-1_:>):3(/-/2L;5\EGO[8)<3A;4CC0M.6SYFM0(]_J
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MY'5;>25E37.O@&]3J&!'%093$ F!W>54MJCDK%R00PPT582RC8)"X"1#N*'
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M4*U.V?5TP_I,([2HG*8S-Q4&\40!UI86-%.AA$XKU#4B$*_9HVS4CX;<E..
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MKO@\E:@43E*L:.=NGV5,XA+E4Q;FU3G<N/B'7R=K H0:(?G,_,B,0NT)\AU
MV4*_%%FJ@,P.^;R2N]6--5"8($9A*Z2VPP0,TPHM^7/,EE3 %G#&:8+.CVEC
M]6+-69^X>Z$>!7?L2$B"#:%D2M"5+.!AR[G,ZQL3(Q2OII7 H4I;D6'$F-<?
M(L*S)11\=<>.^B3POLJ9D.#IA )FH05_52O6RR]YDA E? _-ZGJ;!%"<]-T2
M7H62#T*._G^_^ /N&Q,CM,T;*\W2,OBQRO<*KCFD7DRTH+CI$\5.R+[--P5B
M&_.H+/66(K,C'D^8Z_. J9!)KH0T27%U'7)"P! _WV69N\4<R21S4$CGR:D!
M>&]W.8G-L@R*&0SI(J3F^/:T4<8Y-1><=5PSVYN3LK0BU/1UTVJ?"C5-8I$H
M)=:*B49(;'7QNVW<74,H4AT%6A%J&G DP$YW\1>S ;%D7:YS'A+:X>NQ'F5R
M!.)%3]!UT :WS@E;LQ#*&04,+,DP2#5"L?-#H2\;%$%K,"C%;!'R2A8JC (4
M^$1[PV>#,;IQS%"Z;,U4",%2L!DKU,!JFO6"\'6>A?:",<1P:\9"B6+!6"Q/
M2'X+;3(?.VVR 1@(VKD.XD8H=F/(&?G.#!F3(%J!%D+@0TOI5EO@"_A$,FG*
M=?$TG)-+=TRGT#*J\4EZ=2L:KBD^X9E5GWAK5T7$^'QFXF5;V!'3JHU!\[ N
MM&EE'!;*_?N#*9,(Q6$YGPL'-/, G37=.G.2*)P&5:V"]T#:CA-6Y>NRB+4H
M"6%%3&M "=+-3#%PEN958]]7*CJF* N7W /V.5_\P["*.G(PIET+L1A$99Q#
M%__B!.7"M7EE)2';+:ZGPW*H4,YA5<T5Y%8' OD]U@/?6X,?  <MDTDPDL(D
M0@42'"'43)O"4M ()12$7"T)J0N3>*E;KA$"+E,$@'258("$V9#6A=!RUZ%E
MX3D'*,#<6<:_1J,F<H2NK=-R),C*,.07!HTF[IDJDH2:RRG9AI 3%I(BU*V;
M^S;*!HDA18BR<U-)W/> NUS(U+J+WW,.M4)>(W&M,22$P#!8":DY*!2I)G<=
M6I9<3^J6Z:;U'*$G]B>M^:8'A:D#HQ"7_9ID$YJV/G+ ^VECDJ:V1'G:F@EW
M?42IED@D\-XDY 6D4H3<.$-"V2FE22BY%&6ZDLDG*&S)7DF.F=;7J^@5H)E6
M+4_;3%($P^JTE2XI;Y!L0M..F-9+ENN&'*7&/?&7%__871@AW:^$T!I([1 ]
C.*7T/*8UIV3R"0I;L/]?IS\SGRK=UT\     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
